Diabetes Supplies Articles
SGLT2 Inhibitors: A Promising New Approach in Cancer Treatment
Discover how SGLT2 inhibitors, beyond managing diabetes, are emerging as promising anticancer agents by targeting cancer cell metabolism and inhibiting tumor growth.Cancer remains one of the leading causes of death…
Potential Role of SGLT2 Inhibitors in Autism Spectrum Disorders: A New Horizon in Neuropharmacology
Explore the potential of SGLT2 inhibitors, commonly used for diabetes, as a novel treatment for Autism Spectrum Disorders by reducing oxidative stress and neuroinflammation.Autism Spectrum Disorders (ASD) are a group…
Mapping Insulin Accessibility in Major U.S. Cities: Bridging the Gaps
The rise in diabetes cases across urban areas has turned insulin accessibility into a pressing public health issue. While major U.S. cities are often considered hubs of advanced healthcare systems,…
GLP-1 Receptor Agonists: Exploring Their Potential in Opioid Addiction Treatment
Summary GLP-1 receptor agonists (GLP-1RAs) show potential in treating opioid addiction by reducing cravings and relapse in animal models. While some studies indicate promising results, further research in humans is…
Exploring the Potential of GLP-1 Receptor Agonists in Mitigating Amphetamine-Induced Behaviors: A Comprehensive Review
Summary: GLP-1 receptor agonists (GLP-1RAs) show promise in reducing amphetamine-induced behaviors, including hyperactivity and addiction-related preferences. Preclinical studies using Exendin-4 (Ex-4) have demonstrated its ability to decrease dopamine release in…
How to Get a Synjardy Savings Card and Save on Your Prescription
Summary: The Synjardy Savings Card helps eligible patients save on their prescription costs, often reducing co-pays to as low as $10 per month. This guide explains how to apply, use…
Synjardy 12.5 mg/1000 mg: How It Works to Control Blood Sugar
Summary: Synjardy 12.5 mg/1000 mg is a powerful combination medication for managing type 2 diabetes. Blending empagliflozin and metformin targets insulin resistance and blood sugar regulation simultaneously. This comprehensive approach…
What Is Synjardy Used For? Breaking Down Its Role in Treatment
Summary: Synjardy is a powerful combination medication used to manage type 2 diabetes effectively. Combining empagliflozin and metformin helps lower blood sugar levels and lessen the risk of diabetes-related complications.…
How Synjardy Weight Loss Impacts Your Diabetes Journey
Summary: Synjardy weight loss can be a helpful benefit for individuals with Type 2 diabetes. By combining empagliflozin and metformin, Synjardy not only helps control blood sugar but also promotes…
How to Recognize and Address Synjardy Side Effects
Summary: Synjardy is commonly used to manage Type 2 diabetes by improving blood sugar control. While it is effective, it may cause side effects such as nausea, UTIs, and yeast…
Metformin: A Promising Non-Invasive Therapy for Geographic Atrophy in Age-Related Macular Degeneration
Summary: Metformin, a commonly used medication for diabetes, shows promise as a non-invasive treatment for geographic atrophy (GA), a severe form of age-related macular degeneration (AMD). Recent studies suggest metformin…
When Will Retatrutide Be Available? Insights into the Future of Diabetes and Obesity Care
Summary: Retatrutide is an innovative weight loss medication in Phase 3 trials, designed to target three key hormones to aid in weight loss and improve metabolic health. With its unique…